Investor FAQs

The KaloBios ticker is KBIO and it is traded on NASDAQ.

January 30, 2013.

260 East Grand Avenue
South San Francisco, CA 94080

31 December

Ernst & Young

KaloBios does not currently have a direct stock purchase plan.

Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financial Information portion of our Investor Relations website or directly from the SEC at www.sec.gov.

You can contact KaloBios Investor Relations via our Contact Us web form.

Please submit your question using the form below. * Required fields

 
 
 
 
 
 
This helps KaloBios prevent automated submissions.
 

Shareholder Tools

Search Investor Relations

You are now leaving this website. If you would like to continue, click Continue.
CancelContinue